Delivery of JQ1 (indirect inhibitor of MYC) and a CD47 siRNA in cationic lipid NPs significantly inhibits the expression of PD-L1 and CD47, significantly improving therapeutic efficacy in a mouse model of triple-negative breast cancer 210. This evidence concerns the gene CD47 and triple-negative breast carcinoma.